Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

575
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
575
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

133
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
133

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lacking Evidence.

Deutsches Arzteblatt international·2026
Same author

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

bioRxiv : the preprint server for biology·2026
Same author

Research Letter: Prognostic impact of MRI-derived indexed left ventricular end-diastolic volume (LVEDVi) in individuals with preserved and reduced LV ejection fraction without heart failure in the UK Biobank.

European journal of heart failure·2026
Same author

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

European journal of preventive cardiology·2026
Same author

Associations of ANGPTL3/4/8 proteins and complexes with heart failure and heart failure mortality.

Lipids in health and disease·2026
Same author

CNDP1 (CTG)<sub>5</sub> allele and cardiovascular events in high-risk patients: LURIC study results.

Scientific reports·2026
Same journal

Evidence-Based Clinical Recommendations for the Appropriate Use of Diagnostic Tests in Pediatric Allergology: Focus on Asthma, Rhinoconjunctivitis, and Keratoconjunctivitis Vernal.

Journal of clinical medicine·2026
Same journal

Surgical and Transcatheter Approach of a Failed Mitral Valve Repair: A Comprehensive Review on Selecting the Most Suitable Approach.

Journal of clinical medicine·2026
Same journal

Hybrid Metaheuristic Feature Selection for Breast Cancer Detection in Digital Mammography: A Feasibility Study with Nested Validation, Benchmarking, and External Stress Testing.

Journal of clinical medicine·2026
Same journal

Identity Transformation and the Role of Accountability in Recovery from Problematic Pornography Use: A Phenomenological-Hermeneutical Study.

Journal of clinical medicine·2026
Same journal

Does Early Surgical Treatment in Degenerative Cervical Myelopathy Have a Favorable Clinical Outcome and Impact on Quality of Life?

Journal of clinical medicine·2026
Same journal

Shear Wave Elastography in Musculoskeletal Imaging: A Narrative Review.

Journal of clinical medicine·2026
See all related articles

Related Experiment Video

Updated: Aug 7, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

983

Platelet Reactivity and Cardiovascular Mortality Risk in the LURIC Study.

Martin Berger1, Alexander Dressel2,3, Marcus E Kleber4,5

  • 1Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, 52074 Aachen, Germany.

Journal of Clinical Medicine
|March 11, 2023
PubMed
Summary
This summary is machine-generated.

Platelet reactivity testing predicts mortality risk similar to coronary artery disease. While glucose control and kidney function impact mortality independently, aspirin only benefits high platelet reactivity patients.

Keywords:
CD62pCD63Fibrinogen-bindingcardiovascular mortalityplatelet reactivity

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.8K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

555

Related Experiment Videos

Last Updated: Aug 7, 2025

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

983
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.8K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

555

Area of Science:

  • Cardiology
  • Clinical Pathology

Background:

  • Platelet reactivity (PR) implications in P2Y12-inhibitor naïve patients remain unclear.
  • Understanding PR's role is crucial for cardiovascular risk stratification.

Purpose of the Study:

  • To assess the prognostic value of platelet reactivity.
  • To identify factors modifying mortality risk in patients with altered platelet reactivity.

Main Methods:

  • Flow cytometry measured ADP-induced CD62P and CD63 expression.
  • 1520 patients undergoing coronary angiography in the LURIC study were analyzed.

Main Results:

  • High and low platelet reactivity predicted cardiovascular and all-cause mortality, equivalent to coronary artery disease presence.
  • Glucose control (HbA1c), renal function (eGFR), inflammation (hsCRP), and aspirin therapy modified mortality risk.
  • Aspirin reduced mortality in high platelet reactivity patients only (p=0.02 for CV death).

Conclusions:

  • Platelet reactivity is a significant predictor of cardiovascular mortality, comparable to established coronary artery disease.
  • Improved glucose control, renal function, and reduced inflammation lower mortality risk independently of platelet reactivity.
  • Aspirin therapy demonstrates a mortality benefit specifically in patients with high platelet reactivity.